Everence Capital Management
LH icon

Everence Capital Management’s Labcorp LH Stock Holding History

Everence Capital Management’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.48M Hold
4,820
– – 0.08% 196
2026
Q2 		$1.35M Hold
4,820
– – 0.07% 210
2026
Q1 		$1.29M Hold
4,820
– – 0.08% 208
2025
Q4 		$1.21M Hold
4,820
– – 0.07% 210
2025
Q3 		$1.38M Hold
4,820
– – 0.08% 187
2025
Q2 		$1.26M Hold
4,820
– – 0.08% 198
2025
Q1 		$1.12M Hold
4,820
– – 0.08% 209
2024
Q4 		$1.1M Buy
4,820
+2,710
+128% +$622K 0.07% 212
2024
Q3 		$472K Sell
2,110
-3,300
-61% -$725K 0.03% 442
2024
Q2 		$1.09M Hold
5,410
– – 0.08% 209
2024
Q1 		$1.18M Sell
5,410
-1,890
-26% -$416K 0.08% 206
2023
Q4 		$1.66M Buy
7,300
+3,290
+82% +$691K 0.12% 163
2023
Q3 		$806K Buy
4,010
+1,542
+62% +$325K 0.06% 255
2023
Q2 		$451K Hold
2,468
– – 0.04% 379
2023
Q1 		$486K Hold
2,468
– – 0.04% 374
2022
Q4 		$499K Sell
2,468
-2,398
-49% -$469K 0.04% 371
2022
Q3 		$856K Hold
4,866
– – 0.08% 217
2022
Q2 		$980K Buy
4,866
+722
+17% +$154K 0.09% 188
2022
Q1 		$939K Hold
4,144
– – 0.07% 225
2021
Q4 		$1.12M Hold
4,144
– – 0.08% 204
2021
Q3 		$1M Hold
4,144
– – 0.08% 202
2021
Q2 		$982K Hold
4,144
– – 0.08% 204
2021
Q1 		$908K Hold
4,144
– – 0.08% 198
2020
Q4 		$725K Buy
4,144
+1,676
+68% +$289K 0.07% 234
2020
Q3 		$399K Buy
+2,468
New +$391K 0.04% 365
2017
Q4 		– Sell
-3,108
Closed -$403K – 435
2017
Q3 		$403K Hold
3,108
– – 0.09% 252
2017
Q2 		$412K Hold
3,108
– – 0.1% 245
2017
Q1 		$383K Hold
3,108
– – 0.1% 246
2016
Q4 		$343K Buy
+3,108
New +$345K 0.1% 243

Other funds holding LH

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Boston Partners
Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Everence Capital Management's LH Position: Q3 2026 in Review

Everence Capital Management held its Labcorp (LH) position steady in Q3 2026 at 4,820 shares worth $1.48M. The position accounts for 0.08% of the portfolio, ranked #196.

Everence Capital Management first reported a position in LH in Q4 2016 and has held it in 29 quarters since. The position peaked at $1.66M in Q4 2023. 925 funds tracked by Wall St. Rank hold LH as of Q3 2026.

  • Everence Capital Management held 4,820 shares of Labcorp worth $1.48M as of Q3 2026.
  • Everence Capital Management left its Labcorp share count unchanged in Q3 2026.
  • Labcorp made up 0.08% of Everence Capital Management's portfolio in Q3 2026, its #196 holding.
  • Everence Capital Management first reported a position in Labcorp in Q4 2016 and has held it in 29 quarters since.
  • Everence Capital Management's Labcorp position peaked at $1.66M in Q4 2023.
  • 925 funds tracked by Wall St. Rank held Labcorp as of Q3 2026.

Based on Everence Capital Management's 13F filing for Q3 2026, filed 3 Nov 2026.